comparemela.com
Latest Breaking News On - Montpellier institute of neurosciences - Page 1 : comparemela.com
Bioprojet: WAKIX® (pitolisant) receives approval for the treatment of narcolepsy in children over 6 years of age, a rare, under-diagnosed condition
/PRNewswire/ The European Medicines Agency has just granted an extension of the indication for the marketing authorisation for WAKIX® (pitolisant), which is.
United-states
Paris
France-general
France
Jean-charles-schwartz
Jeanne-marie-lecomte
Yves-dauvilliers
Robin-ganellin-at-university-college-london
Department-of-neurology
Montpellier-institute-of-neurosciences
Walter-schunack-at-berlin-university
European-medicines-agency
Wakix Approved for Narcolepsy Treatment in Children in Europe
The European Medicines Agency approved Wakix for the treatment of narcolepsy in children over 6 years of age, with or without cataplexy.
Bioprojet-wakix
Yves-dauvilliers
Department-of-neurology
European-medicines-agency
Montpellier-institute-of-neurosciences
National-reference-centre-for-narcolepsy
University-of-montpellier
National-reference-centre
Gui-de-chauliac-hospital
Montpellier-institute
vimarsana © 2020. All Rights Reserved.